KPIs & Operating Metrics(New)

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Cardlytics (CDLX) Divestments (2024 - 2025)

Cardlytics' Divestments history spans 2 years, with the latest figure at $300000.0 for Q4 2025.

For Q4 2025, Divestments fell 95.31% year-over-year to $300000.0; the TTM value through Dec 2025 reached $500000.0, down 92.42%, while the annual FY2025 figure was $500000.0, 92.42% down from the prior year.
Divestments reached $300000.0 in Q4 2025 per CDLX's latest filing, up from $200000.0 in the prior quarter.
In the past five years, Divestments ranged from a high of $6.4 million in Q4 2024 to a low of $200000.0 in Q1 2025.